ScholarGate
Assistente

Confronta i metodi

Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.

FACT-Prostate: Functional Assessment of Cancer Therapy×UCLA Prostate Cancer Index×
CampoOncologiaOncologia
FamigliaProcess / pipelineProcess / pipeline
Anno di origine19971998
IdeatoreEsper, P., et al. (built on Cella, D. F. FACT-G framework)Litwin, M. S., et al.
TipoSelf-report questionnaireSelf-report questionnaire
Fonte seminaleEsper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument. Urology, 50(6), 920–928. DOI ↗Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. DOI ↗
AliasFACT-PUCLA PCI, PCI
Correlati55
SintesiThe FACT-Prostate (FACT-P) is a disease-specific quality-of-life instrument for men with prostate cancer, combining the 27-item FACT-G core with a 12-item prostate-specific subscale addressing urinary, sexual, and bowel function concerns. Developed and validated by Esper et al. in 1997, it is a standard outcome measure in prostate cancer clinical trials and clinical practice.The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes.
ScholarGateInsieme di dati
  1. v1
  2. 2 Fonti
  3. PUBLISHED
  1. v1
  2. 2 Fonti
  3. PUBLISHED

Vai alla ricerca Scarica le diapositive

ScholarGateConfronta i metodi: FACT-Prostate · UCLA Prostate Cancer Index. Consultato il 2026-06-19 da https://scholargate.app/it/compare